tiprankstipranks
OncoZenge AB (DE:8LY)
FRANKFURT:8LY
Germany Market
8LY
OncoZenge AB
RESEARCH TOOLSreports

OncoZenge AB (8LY) Ratios

0 Followers

OncoZenge AB Ratios

DE:8LY's free cash flow for Q1 2026 was kr0.00. For the 2026 fiscal year, DE:8LY's free cash flow was decreased by kr and operating cash flow was kr0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.26 1.01 3.09 7.94 10.29
Quick Ratio
 1.26 1.01 3.09 7.94 10.29
Cash Ratio
 0.24 0.44 2.60 7.43 9.98
Solvency Ratio
 -2.02 -1.00 -5.85 4.28 -8.04
Operating Cash Flow Ratio
 -5.41 -1.55 -5.91 -10.05 -7.56
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
kr -6.49Mkr -7.44Mkr 3.10Mkr 11.79Mkr 27.12M
Leverage Ratios
Debt-to-Assets Ratio
 0.64 0.49 0.00 0.00 0.00
Debt-to-Equity Ratio
 20.95 -12.78 0.00 0.00 0.00
Debt-to-Capital Ratio
 0.95 1.08 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.95 1.08 0.00 0.00 0.00
Financial Leverage Ratio
 32.96 -26.13 1.15 1.09 1.09
Debt Service Coverage Ratio
 -45.45 -93.91 0.00 0.00 0.00
Interest Coverage Ratio
 -45.45 -93.91 0.00 0.00 0.00
Debt to Market Cap
 0.07 0.09 0.00 0.00 0.00
Interest Debt Per Share
 0.60 0.63 0.00 0.00 0.00
Net Debt to EBITDA
 -0.29 -0.24 0.44 -1.74 -10.53
Profitability Margins
Gross Profit Margin
100.00%-181.68%100.00%100.00%0.00%
EBIT Margin
-19343.59%-595.72%-868500.00%-530066.67%0.00%
EBITDA Margin
-19343.59%-595.72%-868500.00%242200.00%0.00%
Operating Profit Margin
-19344.44%-595.72%-868500.00%-530066.67%0.00%
Pretax Profit Margin
-19757.26%-598.35%-868800.00%-530066.67%0.00%
Net Profit Margin
-19757.26%-598.35%-868800.00%-530066.67%0.00%
Continuous Operations Profit Margin
-19757.26%-598.35%-868800.00%-530066.67%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%107.06%
EBT Per EBIT
102.13%100.44%100.03%100.00%100.00%
Return on Assets (ROA)
-195.88%-103.93%-75.98%-78.18%-126.44%
Return on Equity (ROE)
-422.19%2715.50%-87.32%-85.31%-137.30%
Return on Capital Employed (ROCE)
-288.02%-229.57%-87.29%-85.31%-128.25%
Return on Invested Capital (ROIC)
-288.02%-229.57%-87.29%-85.31%-128.25%
Return on Tangible Assets
-466.90%-187.82%-189.53%-117.88%-155.26%
Earnings Yield
-23.01%-19.44%-19.78%-43.94%-72.41%
Efficiency Ratios
Receivables Turnover
 0.03 0.56 <0.01 <0.01 0.00
Payables Turnover
 0.00 1.10 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 <0.01 0.17 <0.01 <0.01 0.00
Working Capital Turnover Ratio
 0.22 1.68 <0.01 <0.01 0.00
Cash Conversion Cycle
 12.53K 323.35 263.17K 100.86K 0.00
Days of Sales Outstanding
 12.53K 653.96 263.17K 100.86K 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 330.61 0.00 0.00 0.00
Operating Cycle
 12.53K 653.96 263.17K 100.86K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.61 -1.08 -0.75 -1.46 -1.88
Free Cash Flow Per Share
 -0.62 -1.08 -0.75 -1.46 -1.88
CapEx Per Share
 0.98 1.08 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 0.39 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -1.63 -1.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
 -1.63 -1.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 -2.85 -1.74 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 -182.40 -4.90 -8.76K -5.69K 0.00
Free Cash Flow Yield
-7.79%-15.92%-19.95%-47.20%-34.27%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -4.16 -5.16 -5.07 -2.28 -1.38
Price-to-Sales (P/S) Ratio
 868.10 30.78 43.92K 12.06K 0.00
Price-to-Book (P/B) Ratio
 267.99 -139.70 4.41 1.94 1.90
Price-to-Free Cash Flow (P/FCF) Ratio
 -12.26 -6.28 -5.01 -2.12 -2.92
Price-to-Operating Cash Flow Ratio
 -4.50 -6.28 -5.01 -2.12 -2.92
Price-to-Earnings Growth (PEG) Ratio
 0.04 -0.07 0.11 0.03 >-0.01
Price-to-Fair Value
 267.99 -139.70 4.41 1.94 1.90
Enterprise Value Multiple
 -4.78 -5.41 -4.61 3.24 12.75
Enterprise Value
 112.91M 85.79M 40.06M 23.57M 35.28M
EV to EBITDA
 -4.99 -5.41 -4.61 3.24 12.75
EV to Sales
 965.04 32.20 40.06K 7.86K 0.00
EV to Free Cash Flow
 -13.63 -6.57 -4.57 -1.38 -1.60
EV to Operating Cash Flow
 -5.29 -6.57 -4.57 -1.38 -1.60
Tangible Book Value Per Share
 -0.49 -0.61 0.26 1.01 2.32
Shareholders’ Equity Per Share
 0.03 -0.05 0.85 1.59 2.90
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 -0.07
Revenue Per Share
 <0.01 0.22 <0.01 <0.01 0.00
Net Income Per Share
 -1.74 -1.31 -0.74 -1.36 -3.98
Tax Burden
 1.00 1.00 1.00 1.00 1.07
Interest Burden
 1.02 1.00 1.00 1.00 2.14
Research & Development to Revenue
 78.54 4.14 1.72K 2.46K 0.00
SG&A to Revenue
 124.70 0.00 8.68K 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.92 0.82 1.01 1.07 0.51
Currency in SEK